Radiation-Induced Olfactory Neuroblastoma Following Treatment for NK/T-cell Lymphoma, Nasal Type.

Abstract

Radiation-induced olfactory neuroblastoma (ONB) is an uncommon neoplasm that is generally associated with a poor prognosis. We experienced an unusual case of ONB in a patient who had received previous radiation therapy for extranodal NK/T-cell lymphoma 15 years previously. To our knowledge, this is the first report of a patient with radiation-induced ONB obtaining a complete response (CR) with radical re-irradiation alone. The purpose of this report is to discuss therapeutic strategies for radiation-induced ONB. We report an unusual case of ONB suspected to be a radiation-induced neoplasm in a 33-year-old female who had received 30 Gy of irradiation for extranodal NK/T-cell lymphoma, nasal type (NTCL) 15 years earlier. In this case, the patient presented with nasal obstruction and frequent epistaxis. The patient was diagnosed with ONB based on left nasal biopsy findings. The surrounding normal tissues tolerance of nasal ONB radiation had to be limited, because the previously radiated NTCL was located adjacent to critical organs. We performed intensity modulated radiation therapy (IMRT), which could offer precise irradiation (60 Gy in 2 Gy daily fractions) while sparing critical tissues. The present case was treated with radiation therapy alone, whereas previously reported cases were treated with a combination of chemotherapy and radiation therapy. We treated radiation-induced OBN successfully with radical re-irradiation using IMRT alone and the patient has had no recurrence for 3 years.

• Authors: Koichiro Muraki, Etsuyo Ogo, Gen Suzuki, Hiroaki Suefuji, Hidehiro Eto, Chiyoko Tsuji, Chikayuki Hattori, Yusaku Miyata, Jun Akiba, Toshi Abe
• Journal: The Kurume medical journal (Kurume Med J) Vol. 67 Issue 1 Pg. 41-47 (Mar 11 2022) ISSN: 1881-2090 [Electronic] Japan
• PMID: 34840203 (Publication Type: Case Reports, Journal Article)

Topics

• Adult
• Esthesioneuroblastoma, Olfactory (diagnosis, pathology, radiotherapy)
• Female
• Humans
• Lymphoma, Extranodal NK-T-Cell (diagnosis, drug therapy, pathology)
• Nasal Cavity (pathology, radiation effects)
• Nose Neoplasms (diagnosis, pathology, radiotherapy)
• Radiotherapy, Intensity-Modulated (adverse effects)